Washington: A chemically synthesised version of the drug `rapamycin`, earlier used as an immunosuppressive agent, could be highly effective in treating kidney diseases, scientists have claimed. Scientists at UC Santa Barbara along with a biotech firm based in Indiana found a signalling protein called mTOR was found to drive cyst growth in polycystic kidney disease. Rapamycin inhibited the growth of cysts, the study found.
Modi should learn from Rahul: Misa Bharti
Amar Singh, Jaya Prada join Ajit Singh`s RLD
Modi slams Nitish Kumar in Bihar rally
AAP leader Ashwin Upadhyay calls Arvind Kejriwal `CIA agent`